Literature DB >> 22524842

Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population.

Yi Zhao1, Xin Deng, Zhen Wang, Qiang Wang, Yixia Liu.   

Abstract

AIM: The distribution of DNA repair gene XRCC1 and XRCC3 genotypes was used to assess the potential influence of genetic polymorphisms on risk of colorectal cancer, and interactions with other factors.
METHODS: A 1:2 matched case-control study was conducted with 485 cases and 970 controls. XRCC1 and XRCC2 genotype polymorphisms were based upon duplex polymerase-chain-reaction with the confronting-two-pairprimer (PCR-CTPP) method.
RESULTS: The XRCC1 399Cln allele polymorphism was found to be associated with an increased colorectal cancer risk, while an non-significant inversely association was noted for XRCC3 241Thr/Thr genotype. We also found that individuals with the XRCC1 399 Gln and XRCC3 241Met alleles had an elevated risk, while XRCC3241Thr/Thr was proctective.
CONCLUSION: This study is the first to provide evidence of importance of XRCC1 and XRCC3 gene polymorphisms for risk of colorectal cancer in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524842     DOI: 10.7314/apjcp.2012.13.2.665

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  16 in total

1.  No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study.

Authors:  Fatima Zohra Moghtit; Meriem Samia Aberkane; Valérie Le Morvan; Lotfi Louhibi; Ricardo Bellot; Abdelkader Bousahba; Ahlem Megaiz; Mostefa Fodil; Sounnia Mediene-Benchekor; Faouzia Zemani-Fodil; Abdallah Boudjema; Jacques Robert; Nadhira Saidi-Mehtar
Journal:  Med Oncol       Date:  2014-04-01       Impact factor: 3.064

2.  APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.

Authors:  Shi-Heng Zhang; Lin-Ang Wang; Zheng Li; Yu Peng; Yan-Ping Cun; Nan Dai; Yi Cheng; He Xiao; Yan-Li Xiong; Dong Wang
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  XRCC1 genetic polymorphism acts a potential biomarker for lung cancer.

Authors:  Dao-Qi Zhu; Qiong Zou; Chun-Hong Hu; Jia-Li Su; Guang-Hua Zhou; Ping Liu
Journal:  Tumour Biol       Date:  2015-01-08

Review 4.  XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.

Authors:  Chang-Jiang Qin; Kai-Wu Xu; Zhi-Hui Chen; Er-Tao Zhai; Yu-Long He; Xin-Ming Song
Journal:  Tumour Biol       Date:  2015-01-13

5.  Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk of gastric cancer in Turkey.

Authors:  Ilhami Gok; Meryem Baday; Suleyman Cetinkunar; Kemal Kilic; Bulent Caglar Bilgin
Journal:  Bosn J Basic Med Sci       Date:  2014-09-13       Impact factor: 3.363

6.  Association between XRCC3 p.Thr241Met polymorphism and risk of glioma: A systematic review and meta-analysis.

Authors:  Shing Cheng Tan; Teck Yew Low; Hafiz Muhammad Jafar Hussain; Mohamad Ayub Khan Sharzehan; Hilary Sito; Hamed Kord-Varkaneh; Md Asiful Islam
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

7.  Three polymorphisms of DNA repair gene XRCC1 and the risk of glioma: a case-control study in northwest China.

Authors:  Gaofeng Xu; Maode Wang; Wanfu Xie; Xiaobin Bai
Journal:  Tumour Biol       Date:  2013-09-19

8.  XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.

Authors:  Zhong Tian; Yi-Ling Li; Jin-Gang Liu
Journal:  Mol Biol Rep       Date:  2013-05-28       Impact factor: 2.316

9.  Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.

Authors:  ZhiZhen Wang; Wencheng Zhang
Journal:  Tumour Biol       Date:  2013-03-17

10.  X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.

Authors:  Fu-Ren Zeng; Yang Ling; Jie Yang; Xiao-Cai Tian; Xin Yang; Rong-Cheng Luo
Journal:  Tumour Biol       Date:  2012-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.